Testing effectiveness (Phase 2)Ended earlyNCT02836340
What this trial is testing
TIBOHCA: Safety, Tolerability and Pharmacokinetics of 2-Iminobiotin (2-IB) After OHCA
Who this might be right for
Cardiac ArrestHypoxic Ischemic Brain Injury
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 21